Cited by

• Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.

  Houssami N, Abraham LA, Kerlikowske K, Buist DS, Irwig L, Lee J, Miglioretti DL. Houssami N, et al. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):946-61. doi: 10.1158/1055-9965.EPI-12-1208-T. Epub 2013 Mar 19. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23513042 Free PMC article.
• TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion.

  Giricz O, Calvo V, Peterson EA, Abouzeid CM, Kenny PA. Giricz O, et al. Int J Cancer. 2013 Dec 1;133(11):2587-95. doi: 10.1002/ijc.28295. Epub 2013 Jun 21. Int J Cancer. 2013. PMID: 23729230 Free PMC article.
• Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.

  Neumeister VM, Anagnostou V, Siddiqui S, England AM, Zarrella ER, Vassilakopoulou M, Parisi F, Kluger Y, Hicks DG, Rimm DL. Neumeister VM, et al. J Natl Cancer Inst. 2012 Dec 5;104(23):1815-24. doi: 10.1093/jnci/djs438. Epub 2012 Oct 22. J Natl Cancer Inst. 2012. PMID: 23090068 Free PMC article.
• Emerging treatments for choroidal metastases.

  Chen CJ, McCoy AN, Brahmer J, Handa JT. Chen CJ, et al. Surv Ophthalmol. 2011 Nov-Dec;56(6):511-21. doi: 10.1016/j.survophthal.2011.05.001. Surv Ophthalmol. 2011. PMID: 22117885 Free PMC article. Review.
• The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer.

  Iyengar P, Strom EA, Zhang YJ, Whitman GJ, Smith BD, Woodward WA, Yu TK, Buchholz TA. Iyengar P, et al. Oncologist. 2012;17(11):1402-8. doi: 10.1634/theoncologist.2012-0170. Epub 2012 Sep 14. Oncologist. 2012. PMID: 22982581 Free PMC article.